Re:Injecting the flu vaccine into a tumor gets the immune sy...
by rayiner on Sunday January 12, 2020 @10:47AM
(#22026759)
This makes no sense. Whoever invents a cure for cancer will have the market cornered and make a ton of money. Drug companies have tremendous incentives to do that. This isn’t a theoretical economic point. It’s exactly what’s happening with Hep C.
[ Parent
| on HN ]
Re:Injecting the flu vaccine into a tumor gets the immune sy...
by justsid on Sunday January 12, 2020 @12:27PM
(#22027534)
Not only that, but someone living past 30 is probably going to need a bunch more health treatments in life. Sure you can milk the dying cancer patient one time a lot, but that’s that then. A cancer survivor is coming back to pay more money to live even longer later.
Re:Injecting the flu vaccine into a tumor gets the immune sy...
by redis_mlc on Sunday January 12, 2020 @06:37PM
(#22030542)
> Whoever invents a cure for cancer will have the market cornered and make a ton of money. Drug companies have tremendous incentives to do that.
Where to start ...
1) Cancer isn't one disease, it's hundreds. If you live to 110, you will die from cancer.
2) Pharmas don't want a cure. They want a daily dose for 40 years like Rogaine. That's how they make money.
Re:Injecting the flu vaccine into a tumor gets the immune sy...
by xyzzyz on Sunday January 12, 2020 @08:00PM
(#22030996)
> 2) Pharmas don't want a cure. They want a daily dose for 40 years like Rogaine. That's how they make money.
Why did they invent Hep C cure then? Sofosbuvir was invented in 2007, and approved in the US for 2013. It cures Hepatitis C, which previously required regular doses of drugs. Why did Pharmasset decide to look for a cure instead of regular daily doses? Why did Gilead buy Pharmasset for $11B? Please, explain how it fits into your economic model of healthcare.
Re:Injecting the flu vaccine into a tumor gets the immune sy...
by rhoyerboat on Sunday January 12, 2020 @01:52PM
(#22028268)
assuming the cure isn't open-source/ otherwise impossible to patent and is basically garage-fab easy. ~84K for a course of hep C meds? insulin costing ~6k per patient per year? i see an incredible incentive to provide a more cost-effective treatment yes, but also see that drug companies have incredible incentives to suppress research they cannot control.